2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Conditions
Colitis, Ulcerative
3
Urogenital Neoplasms
2
Inflammatory Bowel Diseases
2
Crohn Disease
2
Colitis
2
Carcinoma, Non-Small-Cell Lung
2
Takayasu Arteritis
1
Recurrence
1
Melanoma
1
Lung Neoplasms
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Interventions
Adalimumab
19
Etanercept
16
Methotrexate
11
Infliximab
8
tocilizumab
7
Rituximab
7
golimumab
6
Abatacept
6
tofacitinib
5
Tumor Necrosis Factor Inhibitors
5
olokizumab
4
Certolizumab Pegol
4
Antirheumatic Agents
3
Saline Solution
2
RC-18
2
Nivolumab
2
Leflunomide
2
veltuzumab
1
upadacitinib
1
secukinumab
1
sarilumab
1
mavrilimumab
1
entecavir
1
cabozantinib
1
baricitinib
1
andecaliximab
1
Vitamin D
1
Vaccines
1
TACI receptor-IgG Fc fragment fusion protein
1
Syringes
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Arthritis, Rheumatoid
×
CT-P13
×
Clear all
NCT03348046
2020-03-04
PASSRRA
Hikma Pharmaceuticals LLC
Completed
22 enrolled